Cited by 598Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsSingle-cell and spatial transcriptomics

A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research

Open access
De Jager, Philip L., Ma, Yiyi, McCabe, Cristin, Xu, Jishu, Vardarajan, Badri N., Felsky, Daniel, Klein, Hans-Ulrich, White, Charles C. +10 more·2018·Scientific Data

Published version of a preprint

Abstract

We initiated the systematic profiling of the dorsolateral prefrontal cortex obtained from a subset of autopsied individuals enrolled in the Religious Orders Study (ROS) or the Rush Memory and Aging Project (MAP), which are jointly designed prospective studies of aging and dementia with detailed, longitudinal cognitive phenotyping during life and a quantitative, structured neuropathologic examination after death. They include over 3,322 subjects. Here, we outline the first generation of data including genome-wide genotypes (n=2,090), whole genome sequencing (n=1,179), DNA methylation (n=740), chromatin immunoprecipitation with sequencing using an anti-Histone 3 Lysine 9 acetylation (H3K9Ac) antibody (n=712), RNA sequencing (n=638), and miRNA profile (n=702). Generation of other omic data including ATACseq, proteomic and metabolomics profiles is ongoing. Thanks to its prospective design and recruitment of older, non-demented individuals, these data can be repurposed to investigate a large number of syndromic and quantitative neuroscience phenotypes. The many subjects that are cognitively non-impaired at death also offer insights into the biology of the human brain in older non-impaired individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sdata.2018.142

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Early EWAS identified differentially methylated regions in genes including ANK1 and BIN1, suggesting that epigenetic modifications may converge on biological pathways previously implicated by genetic studies.

    “Early epigenome-wide association studies (EWAS) identified differentially methylated regions (DMRs) in genes including ankyrin 1 (ANK1) and BIN1, suggesting that epigenetic modifications may converge on biological pathways previously implicated by genetic studies124,152.”

    From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [124]

    The References section cites an earlier study titled “Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci,” and Technical Validation says methylation findings were replicated. But this atlas does not itself state that the findings were differentially methylated regions or draw the proposed connection to pathways implicated by genetic studies. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • Large-scale studies such as ROS/MAP have used multi-omic data from dorsolateral prefrontal cortex tissue to identify Alzheimer's disease subtypes that exhibit distinct cognitive trajectories.

    “Large-scale studies such as ROS/MAP project have utilized multi-omic data from dorsolateral prefrontal cortex tissue to identify AD subtypes that exhibit distinct cognitive trajectories.”

    From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [124]

    The Background & Summary describes multi-omic data from ROSMAP dorsolateral prefrontal cortex tissue and a measure of each participant’s cognitive-decline trajectory (page not provided). It does not report using those data to identify Alzheimer’s disease subtypes with distinct cognitive trajectories. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • AMP-AD resource includes post mortem RNA-seq datasets from ROSMAP, MSSM, and Mayo Clinic, encompassing >1200 individuals across seven brain regions.

    “This resource includes post mortem RNA‐seq datasets from the Religious Orders Study and Memory and Aging Project (ROSMAP) 40 , Mount Sinai School of Medicine (MSSM), 39 and Mayo Clinic, 38 encompassing > 1200 individuals across seven brain regions (Figure 6A).”
  • The DLPFC controls working memory and executive function and is a key neocortical region affected in AD.

    “The DLPFC controls working memory and executive function and is a key neocortical region affected in AD.”
  • Bulk RNA-Seq cannot resolve cell-specific transcriptional changes due to tissue heterogeneity.

    “Despite these advances, bulk RNA-Seq cannot resolve cell-specific transcriptional changes due to tissue heterogeneity122,124.”

    From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [124]

    The Methods sections on RNA Sample Preparation and RNA Sequencing describe extracting RNA from frontal-cortex tissue and measuring gene expression, but do not discuss whether bulk RNA-seq can resolve cell-specific changes. Searches for cell types and tissue heterogeneity found no passage making that claim; the mention of cellular heterogeneity appears only in a reference title about DNA methylation. (LLM, conf=0.73)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 10

  1. Synapse 2016 https://dx.doi.org/10.7303/syn2580853 · DOI
  2. Synapse 2016 https://dx.doi.org/10.7303/syn3219045 · DOI
  3. Synapse 2016 https://dx.doi.org/10.7303/syn3157322 · DOI
  4. Synapse 2016 https://dx.doi.org/10.7303/syn3157325 · DOI
  5. Synapse 2016 https://dx.doi.org/10.7303/syn3157329 · DOI
  6. Synapse 2017 https://dx.doi.org/10.7303/syn10901595 · DOI
  7. Synapse 2016 https://dx.doi.org/10.7303/syn3388564 · DOI
  8. Synapse 2016 https://dx.doi.org/10.7303/syn3387325 · DOI
  9. Synapse 2016 https://dx.doi.org/10.7303/syn4896408 · DOI
  10. Synapse 2017 https://dx.doi.org/10.7303/syn3157275 · DOI

Cited by

Sorted by citations

Authors
De Jager, P. L., Ma, Y., McCabe, C., Xu, J., Vardarajan, B. N., Felsky, D., Klein, H.-U., White, C. C., Peters, M. A., Lodgson, B., Nejad, P., Tang, A., Mangravite, L. M., Yu, L., Gaiteri, C., Mostafavi, S., Schneider, J. A., & Bennett, D. A.
Affiliations
  • Columbia University Irving Medical Center (US)
  • Broad Institute (US)
  • Sage Bionetworks (US)
  • Rush University Medical Center (US)
  • University of British Columbia (CA)
Corresponding author
Bennett, David A.
Venue
Scientific Data
Published
2018-08-07
Volume
5
Issue
1
Pages
180142-180142
ISSN
2052-4463 (ISSN-L)
OpenAlex
W2950886245
Cited by
598
References
48
Citations by year
2026: 69 · 2025: 83 · 2024: 125 · 2023: 76 · 2022: 82 · 2021: 74 · 2020: 58 · 2019: 23 · 2018: 4 · 2013: 1 · 2012: 1
Type
data paper
Language
en
Open access
Locations
  • Scientific Data (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Broad Institute
  • National Institutes of Health (K25 AG04190601, R01AG03-6836, AG016574, AG10161, AG15819)
  • National Institute on Aging (R01AG017917, K25AG041906, R01AG030146, R01AG042210, R01AG018023, R01AG036836, U01AG046152, R01AG011101, K08AG034290, R01AG036042, R01AG043617, R01AG015819, P30AG010161, RC2AG036547, R01AG032990, RF1AG015819, RF1AG036042, P50AG016574)
  • National Institute of Environmental Health Sciences (U01ES017155)
  • National Center for Research Resources (KL2RR024151)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
dorsolateral prefrontal cortex, Alzheimer's disease, Religious Orders Study, Rush Memory and Aging Project, DNA methylation, H3K9 acetylation, chromatin accessibility, transcriptome, microRNA, neuropathology
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Female, Frontal Lobe, Humans, Male, Genome, Human, Sequence Analysis, RNA, DNA Methylation, Proteomics, Chromatin Immunoprecipitation, Metabolomics, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review